nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

28.09.2018 | Review

From dengue to Zika: the wide spread of mosquito-borne arboviruses

verfasst von: Shivani Sukhralia, Mansi Verma, Shruthi Gopirajan, P. S. Dhanaraj, Rup Lal, Neeti Mehla, Chhaya Ravi Kant

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

The worldwide invasion of arthropod-borne viruses (arboviruses) in recent decades is responsible for emerging public health threats. Some factors like climate change, urbanisation and uncontrolled population growth are fuelling their widespread. Arboviruses incorporate a vast collection of genetically diverse viral pathogens including that of dengue, Zika and chikungunya. These viruses are peculiar as they are zoonotic and are a serious harm to the society, with no particular therapy to neutralise their effect. So it is the need of the hour to develop an effective treatment against infections caused by them. This review focuses on some of the common families of mosquito-borne arboviruses and their most known members that are a threat to mankind and discusses their genome organisation, worldwide spread and negative influence on public health.

Liang G, Gao X, Gould EA (2015) Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control. Emerg Microbes Infec 4:e18. https://doi.org/10.1038/emi.2015.18 CrossRef

Gould E, Pettersson J, Higgs S, Charrel R, de Lambalerrie X (2017) Emerging arboviruses: why today? Open Health 4:1–13. https://doi.org/10.1016/j.onehlt.2017.06.001 CrossRef

Kuno G, Chang GJ (2005) Biological transmission of arboviruses: re-examination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends. Clin Microbiol Rev 18:608–637. https://doi.org/10.1128/CMR.18.4.608-637.2005 CrossRefPubMedPubMedCentral

Shope RE, Bunyaviruses, in: Baron S, editor, Medical microbiology, fourth ed, Galveston (TX): University of Texas Medical Branch at Galveston; 1996, Chapter 56. https://www.ncbi.nlm.nih.gov/books/NBK8004/

Calisher CH (1994) Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 7:89–116 https://www.ncbi.nlm.nih.gov/pubmed/8118792 CrossRefPubMedPubMedCentral

Brinton MA, Basu M Functions of the 3′ and 5′ genome RNA regions of members of the genus Flavivirus. Virus Res 206(201):108–119. https://doi.org/10.1016/j.virusres.2015.02.006

Schmaljohn AL, McClain D (1996) Alphaviruses (Togaviridae) and Flaviviruses (Flaviviridae). In: Baron S, editor. Medical microbiology, fourth ed. University of Texas Medical Branch at Galveston, Galveston (TX) Chapter 54. https://www.ncbi.nlm.nih.gov/books/NBK7633/

Mackenzie JS, Gubler DJ, Petersen LR (2004) Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10:98–109. https://doi.org/10.1038/nm1144 CrossRef

Paula T, Pablo R, Eugenia V, Pablo B, Sabino P, Jose M, Vincente S (2009) New drug targets for hepatitis C and other Flaviviridae viruses. Infect Disord Drug Targets 9:133–147. https://doi.org/10.2174/187152609787847749 CrossRefPubMed

10.

Gardner CL, Ryman KD (2010) Yellow fever: a reemerging threat. Clin LabMed 30(1):237–260. https://doi.org/10.1016/j.cll.2010.01.001 CrossRef

11.

Couto-Lima D, Madec Y, Bersot MI, Campos SS, Motta MDA, Santos FBD et al (2017) Potential risk of re-emergence of urban transmission of yellow fever virus in Brazil facilitated by competent Aedes populations. Sci Rep 7:4848. https://doi.org/10.1038/s41598-017-05186-3 CrossRefPubMedPubMedCentral

12.

McElroy KL, Tsetsarkin KA, Vanlandingham DL, Higgs S (2006) Role of the yellow fever virus structural protein genes in viral dissemination from the Aedes aegypti mosquito midgut. J Gen Virol 87:2993–3001. https://doi.org/10.1099/vir.0.82023-0 CrossRefPubMed

13.

Ortiz-Martínez Y, Patiño-Barbosa AM, Rodriguez-Morales AJ (2017) Yellow fever in the Americas: the growing concern about new epidemics. F1000Research 6:398. https://doi.org/10.12688/f1000research.11280.2 CrossRefPubMedPubMedCentral

14.

Weaver SC, Reisen WK (2010) Present and future arboviral threats. Antivir Res 85:328–345. https://doi.org/10.1016/j.antiviral.2009.10.008 CrossRefPubMed

15.

Guzman MG, Halstead SB, Artsob H et al (2010) Dengue: a continuing global threat. Nat. Rev. Microbiol. 8:S7–S16. https://doi.org/10.1038/nrmicro2460

16.

GBD Disease and Injury Incidence and Prevalence Collaborators (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1545–1602CrossRef

17.

Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL et al (2013) The global distribution and burden of dengue. Nature 496:504–507. https://doi.org/10.1038/nature12060 CrossRefPubMedPubMedCentral

18.

Shuzhen S, Martin L, Hibberd ML (2016) Genomic approaches for understanding dengue: insights from the virus, vector, and host. Genome Biol 17:38. https://doi.org/10.1186/s13059-016-0907-2 CrossRef

19.

Gebhard LG, Filomatori CV, Gamarnik AV (2011) Functional RNA elements in the dengue virus genome. Viruses 3:1739–1756. https://doi.org/10.3390/v3091739 CrossRefPubMedPubMedCentral

20.

Zeidler JD, Fernandes-Siqueira LO, Barbosa GM, Da Poian AT (2017) Non-canonical roles of dengue virus non-structural proteins. Viruses 9:42. https://doi.org/10.3390/v9030042 CrossRefPubMedCentral

21.

Vasilakis N, Cardosa J, Hanley NA, Holmes C, Weaver SC (2011) Fever from the Forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol 9:532–541. https://doi.org/10.1038/nrmicro2595 CrossRefPubMedPubMedCentral

22.

Yung CF, Lee KS, Thein TL, Tan LK, Gan VC, Wong JGX, Leo YS (2015) Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, Singapore. Am J Trop Med Hyg 92:999–1005. https://doi.org/10.4269/ajtmh.14-0628 CrossRefPubMedPubMedCentral

23.

Guzman MG, Kouri G (2003) Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 27:1–13. https://doi.org/10.1016/S1386-6532(03)00010-6 CrossRefPubMed

24.

Balmaseda A, Hammond SN, Perez L, Tellez Y, Saborio SI, Mercado JC, Cuadra R, Rocha J, Perez MA, Silva S, Rocha C, Harris E (2003) Serotype-specific differences in clinical manifestations of dengue. Am. J. Trop. Med. Hyg 74:449–456 https://www.ncbi.nlm.nih.gov/pubmed/16525106 CrossRef

25.

Coudeville L, Baurin N, L’Azou M, Guy B (2016) Potential impact of dengue vaccination: insights from two large-scale phase III trials with a tetravalent dengue vaccine. Vaccine 34:6426–6435. https://doi.org/10.1016/j.vaccine.2016.08.050 CrossRefPubMed

26.

Pastula DM, Smith DE, Beckham JD, Tyler KL (2016) Four emerging arboviral diseases in North America: Jamestown Canyon, Powassan, chikungunya, and Zika virus diseases. J Neurovirol 22:257–260. https://doi.org/10.1007/s13365-016-0428-5 CrossRefPubMedPubMedCentral

27.

Musso D, Gubler DJ (2016) Zika virus. Clin Microbiol Rev 29:487–524. https://doi.org/10.1128/CMR.00072-15 CrossRefPubMedPubMedCentral

28.

Alam A, Ali S, Ahamad S, Malik MZ, Ishrat R (2016) From ZikV genome to vaccine: in silico approach for the epitope based peptide vaccine against Zika virus envelope glycoprotein. Immunology 149:386–399. https://doi.org/10.1111/imm.12656 CrossRefPubMedPubMedCentral

29.

Lowe R, Barcellos C, Brasil P et al (2018) The Zika virus epidemic in Brazil: from discovery to future implications. Int J Environ Res Public Health 15:96. https://doi.org/10.3390/ijerph15010096 CrossRefPubMedCentral

30.

Marini G, Guzzetta G, Rosà R, Merler S (2017) First outbreak of Zika virus in the continental United States: a modelling analysis. Eur Secur 22(37):30612. https://doi.org/10.2807/1560-7917.ES.2017.22.37.30612 CrossRef

31.

Saiz J-C, Vázquez-Calvo Á, Blázquez AB, Merino-Ramos T, Escribano-Romero E, Martín-Acebes MA (2016) Zika virus: the latest newcomer. Front. Microbiol 7:496. https://doi.org/10.3389/fmicb.2016.00496 CrossRefPubMedPubMedCentral

32.

Gyawali N, Bradbury RS, Andrew W, Taylor-Robinson AW (2016) The global spread of Zika virus: is public and media concern justified in regions currently unaffected? Infect. Dis. Poverty 5:37. https://doi.org/10.1186/s40249-016-0132-y CrossRefPubMedPubMedCentral

33.

Haddow A, Schuh A, Yasuda C, Kasper M, Heang V, Huy R, Guzman H, Tesh R, Weaver S (2012) Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Neglect TropDis 6:1477. https://doi.org/10.1371/journal.pntd.0001477 CrossRef

34.

Tang BL (2016) Zika virus as a causative agent for primary microencephaly: the evidence so far. Arch. Microbiol. 198:595–601. https://doi.org/10.1007/s00203-016-1268-7 CrossRefPubMed

35.

Morrison C (2016) DNA vaccines against Zika virus speed into clinical trials. Nat Rev Drug Discov 15:521–522. https://doi.org/10.1038/nrd.2016.159 CrossRefPubMed

36.

Yun SI, Lee YM (2014) Japanese encephalitis: the virus and vaccines. Hum. Vaccin. Immunother 10:263–279. https://doi.org/10.4161/hv.26902 CrossRefPubMed

37.

Wang H, Liang G (2015) Epidemiology of Japanese encephalitis: past, present, and future prospects. Ther Clin Risk Manag 11:435–448. https://doi.org/10.2147/TCRM.S51168 CrossRefPubMedPubMedCentral

38.

Solomon T, Vaughn DW (2002) Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 267:171–194 https://www.ncbi.nlm.nih.gov/pubmed/12082989 PubMed

39.

Solomon T, Ni H, Beasley DWC, Ekkelenkamp M, Cardosa MJ, Barrett ADT (2003) Origin and evolution of Japanese encephalitis virus in Southeast Asia. J.Virol. 77:3091–3098. https://doi.org/10.1128/JVI.77.5.3091-3098.2003 CrossRefPubMedPubMedCentral

40.

Tiwari S, Singh KR, Tiwari R, Dhole TN (2012) Japanese encephalitis: a review of the Indian perspective. Braz J Infect Dis 16:564–573. https://doi.org/10.1016/j.bjid.2012.10.004 CrossRefPubMed

41.

Amicizia D, Zangrillo F, Lai PL, Iovine M, Panatto D (2018) Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®). J. Prev. Med. Hyg 59:E99–E107. https://doi.org/10.15167/2421-4248/jpmh2018.59.1.962 CrossRefPubMedPubMedCentral

42.

Barrows NJ, Campos RK, Liao K-C et al (2018) Biochemistry and molecular biology of flaviviruses. Chem. Rev. 118:4448–4482. https://doi.org/10.1021/acs.chemrev.7b00719 CrossRefPubMedPubMedCentral

43.

Basu A, Dutta K (2017) Recent advances in Japanese encephalitis, Version 1. F1000Res 6:259. https://doi.org/10.12688/f1000research.9561.1 CrossRefPubMedPubMedCentral

44.

Smithburn KC, Hughes TP, Burke AW, Paul JH (1940) A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 20:471–492 https://www.cabdirect.org/cabdirect/abstract/19412700112 CrossRef

45.

Hayes C (2002) West Nile virus: Uganda, 1937, to New York City, 1999. Ann. NY Acad. Sci. 951:25–37 https://www.ncbi.nlm.nih.gov/pubmed/11797781 CrossRef

46.

Blitvich B (2008) Transmission dynamics and changing epidemiology of West Nile virus. Anim Health Res Rev 9:71–86. https://doi.org/10.1017/S1466252307001430 CrossRefPubMed

47.

Berthet FX, Zeller HG, Drouet MT, Rauzier J, Digoutte JP, Deubel V (1997) Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J Gen Virol 78:2293–2297. https://doi.org/10.1099/0022-1317-78-9-2293 CrossRefPubMed

48.

Scherret JH, Poidinger M, Mackenzie JS, Broom AK, Deubel V, Lipkin WI, Briese T, Gould EA, Hall RA (2001) The relationships between West Nile and Kunjin virus. Emerg Infect Dis 7:697–705. https://doi.org/10.3201/eid0704.010418 CrossRefPubMedPubMedCentral

49.

Burt FJ, Grobbelaar AA, Leman PA, Anthony FS, Gibson GVF, Swanepoel R (2002) Phylogenetic relationships of southern African West Nile virus isolates. Emerg Infect Dis 8:820–826 https://wwwnc.cdc.gov/eid/article/8/8/02-0027_article CrossRefPubMedPubMedCentral

50.

Bakonyi T, Ivanics É, Erdélyi K, Ursu K, Ferenczi E, Weissenböck H, Nowotny N (2006) Lineage 1 and 2 strains of encephalitic West Nile virus, Central Europe. Emerg Infect Dis 12:618–623. https://doi.org/10.3201/eid1204.051379 CrossRefPubMedPubMedCentral

51.

Rossi SL, Ross TM, Evans JD (2010) West Nile Virus. Clin Lab Med 30:47–65. https://doi.org/10.1016/j.cll.2009.10.006 CrossRefPubMedPubMedCentral

52.

Hollidge BS, González-Scarano F, Soldan SS (2010) Arboviral encephalitides: transmission, emergence, and pathogenesis. J. Neuroimmune Pharmacol. 5:428–442. https://doi.org/10.1007/s11481-010-9234-7 CrossRefPubMedPubMedCentral

53.

Rossini G, Landini MP, Gelsomino F, Sambri V, Varani S (2013) Innate host responses to West Nile virus: implications for central nervous system immunopathology. World J. Virol. 2:49–56. https://doi.org/10.5501/wjv.v2.i2.49 CrossRefPubMedPubMedCentral

54.

Leis AA, Stokic DS (2012) Neuromuscular manifestations of West Nile virus infection. Front. Neurol 3:37. https://doi.org/10.3389/fneur.2012.00037 CrossRefPubMedPubMedCentral

55.

Petersen LR, Brault AC, Nasci RS (2013) West Nile virus: review of the literature. JAMA 310:308–315. https://doi.org/10.1001/jama.2013.8042 CrossRefPubMedPubMedCentral

56.

Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland ME (2003) Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 349:1236–1245. https://doi.org/10.1056/NEJMoa030969 CrossRefPubMed

57.

Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L (2013) Chikungunya virus infection: an overview. New Microbiol 36:211–227 https://www.ncbi.nlm.nih.gov/pubmed/23912863 PubMed

58.

Lo Presti A, Lai A, Cella E, Zehender G, Ciccozzi M (2016) Chikungunya virus, epidemiology, clinics and phylogenesis: a review. Asian Pac J Trop Med 7:925–932. https://doi.org/10.1016/S1995-7645(14)60164-4 CrossRef

59.

Carrera JP, Díaz Y, Denis B, et al (2017) Unusual pattern of chikungunya virus epidemic in the Americas, the Panamanian experience. Aguilar PV, ed., PLoS Negl Tropl Dis 11, 2. https://doi.org/10.1371/journal.pntd.0005338

60.

Organization PH. Chikungunya [Internet], Available: https://www.paho.org/hq/dmdocuments/2014/2014-dec-29-cha-CHIKV-cases-ew-52.pdf

61.

Simizu B, Yamamoto K, Hashimoto K, Ogata T (1984) Structural proteins of chikungunya virus. J Virol 51:254–258 https://www.ncbi.nlm.nih.gov/pubmed/6726893 PubMedPubMedCentral

62.

Hrnjaković Cvjetković IB, Cvjetković D, Patić A, Nikolić N, Stefan Mikić S, Milošević V (2015) Chikungunya—a serious threat for public health. Med Pregl 68:122–125. https://doi.org/10.2298/MPNS1504122H CrossRefPubMed

63.

Eifan S, Schnettler E, Dietrich I, Kohl A, Blomström A-L (2013) Non-structural proteins of arthropod-borne bunyaviruses: roles and functions. Viruses 5:2447–2468. https://doi.org/10.3390/v5102447 CrossRefPubMedPubMedCentral

64.

Elliott RM (2009) Bunyaviruses and climate change. Clin Microbiol Infect 15:510–517. https://doi.org/10.1111/j.1469-0691.2009.02849.x CrossRefPubMed

65.

Horne KM, Vanlandingham DL (2014) Bunyavirus–vector interactions. Viruses 6:4373–4397. https://doi.org/10.3390/v6114373 CrossRefPubMedPubMedCentral

66.

Ikegami T, Makino S (2009) Rift Valley fever vaccines. Vaccine 27:69–72. https://doi.org/10.1016/j.vaccine.2009.07.046 CrossRef

67.

Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J (2010) Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41:61 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896810/ CrossRefPubMedPubMedCentral

68.

Mansfield KL, Banyard AC, McElhinney L, Johnson N, Horton DL, Hernández-Triana LM, Fooks AR (2015) Rift Valley fever virus: a review of diagnosis and vaccination, and implications for emergence in Europe. Vaccine 33:5520–5531. https://doi.org/10.1016/j.vaccine.2015.08.020 CrossRefPubMed

69.

http://www.who.int/news-room/fact-sheets/detail/rift-valley-fever [cited on 16.2.2018]

70.

Ikegami T, Makino S (2011) The pathogenesis of Rift Valley fever. Viruses 3:493–519. https://doi.org/10.3390/v3050493 CrossRefPubMedPubMedCentral

71.

Attoui H, Mertens PPC, Becnel J, Belaganahalli S, Bergoin M et al (2011) Ninth Report of the International Committee on Taxonomy of Viruses. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (eds) Family: Reoviridae. Elsevier/Academic Press, London, pp 541–637 ISBN: 0123846846978-0-12-384684-6

72.

Lamrani A, Tubert-Bitter P, Hill C, Escolano S (2017) A benefit–risk analysis of rotavirus vaccination, France, 2015. Eurosurveillance 22:17–00041. https://doi.org/10.2807/1560-7917.ES.2017.22.50.17-00041 CrossRefPubMedCentral

73.

Miyazaki N, Uehara-Ichiki T, Xing L, Bergman L, Higashiura A, Nakagawa A, Omura T, Cheng RH (2008) Structural evolution of Reoviridae revealed by Oryzavirus in acquiring the second capsid shell. J. Virol. 82:11344–11353. https://doi.org/10.1128/JVI.02375-07 CrossRefPubMedPubMedCentral

74.

Danthi P, Holm GH, Stehle T, Dermody TS (2013) Reovirus receptors, cell entry and proapoptotic signaling. Adv Exp Med Biol 790:42–71. https://doi.org/10.1007/978-1-4614-7651-1_3 CrossRefPubMedPubMedCentral

75.

Clarke P, Debiasi RL, Goody R, Hoyt CC, Richardson-Burns S, Tyler KL (2005) Mechanisms of reovirus induced cell death and tissue injury: role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation. Viral Immunol 18:89–115. https://doi.org/10.1089/vim.2005.18.89 CrossRefPubMed

76.

Attoui H, Mendez-Lopez MR, Rao S, Hurtado-Alendes A, Lizaraso-Caparo F, Jaafar FM, Samuel AR, Belhouchet M, Pritchard LI, Melville L, Weir RP, Hyatt AD, Davis SS, Lunt R, Calisher CH, Tesh RB, Fujita R, Mertens PP (2009) Peruvian horse sickness virus and Yunnan orbivirus, isolated from vertebrates and mosquitoes in Peru and Australia. Virol 394:298–310. https://doi.org/10.1099/vir.0.81258-0 CrossRef

77.

MohdJaafar F, Belhouchet M, Belaganahalli M, Tesh RB, Mertens PPC, Attoui H (2014) Full-genome characterisation of Orungo, Lebombo and Changuinola viruses provides evidence for co-evolution of orbiviruses with their arthropod vectors, Qiu J, ed., PLoS ONE, 9.1, e86392. https://doi.org/10.1371/journal.pone.0086392

78.

Attoui H, Jaafar FM, de Micco P, de Lamballerie X (2005) Coltiviruses and seadornaviruses in North America, Europe, and Asia. Emerg Infect Dis 11:1673–1679. https://doi.org/10.3201/eid1111.050868 CrossRefPubMedPubMedCentral

79.

Weiss S, Dabrowski PW, Kurth A, Leendertz SAJ, Leendertz FH (2017) A novel Coltivirus-related virus isolated from free-tailed bats from Côte d’Ivoire is able to infect human cells in vitro. Virol. J. 14:181. https://doi.org/10.1186/s12985-017-0843-0 CrossRefPubMedPubMedCentral

80.

Wong AH, Cheng PKC, Lai MYY et al (2012) Virulence potential of fusogenic orthoreoviruses. Emerg. Infect. Dis. 18:944–948. https://doi.org/10.3201/eid1806.111688 CrossRefPubMedPubMedCentral

81.

Brower V (2001) Vector-borne diseases and global warming: are both on an upward swing?: Scientists are still debating whether global warming will lead to a further spread of mosquitoes and the diseases they transmit. EMBO Rep. 2:755–757. https://doi.org/10.1093/embo-reports/kve193 CrossRefPubMedPubMedCentral

82.

Franz AWE, Kantor AM, Passarelli AL, Clem RJ (2015) Tissue barriers to arbovirus infection in mosquitoes. Viruses 7:3741–3767. https://doi.org/10.3390/v7072795 CrossRefPubMedPubMedCentral

83.

Lim EXY, Lee WS, Madzokere ET, Herrero LJ (2018) Mosquitoes as suitable vectors for Alphaviruses. Viruses 10:84. https://doi.org/10.3390/v10020084 CrossRefPubMedCentral

84.

Huang Y-JS, Higgs S, Vanlandingham DL (2017) Biological control strategies for mosquito vectors of arboviruses. Insects 8:21. https://doi.org/10.3390/insects8010021 CrossRefPubMedCentral

85.

Araújo HRC, Carvalho DO, Ioshino RS, Costa-da-Silva AL, Capurro ML (2015) Aedes aegypti control strategies in Brazil: incorporation of new technologies to overcome the persistence of dengue epidemics. Forschler BT, ed., Insects, 6,576–594. https://doi.org/10.3390/insects6020576

86.

Alphey L, McKemey A, Nimmo D et al (2013) Genetic control of Aedes mosquitoes. Pathog GlobHealth 107:170–179. https://doi.org/10.1179/2047773213Y.0000000095 CrossRef

87.

Kamtchum-Tatuene J, Makepeace BL, Benjamin L, Baylis M, Solomon T (2017) The potential role of Wolbachia in controlling the transmission of emerging human arboviral infections. Curr Opin Infect Dis 30:108–116. https://doi.org/10.1097/QCO.0000000000000342 CrossRefPubMedPubMedCentral

88.

Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL (2005) Comparative genomics of foot-and-mouth disease virus. J Virol 79:6487–6504. https://doi.org/10.1128/JVI.79.10.6487-6504.2005 CrossRefPubMedPubMedCentral

89.

Jun S-R, Leuze MR, Nookaew I, et al (2015) Ebolavirus comparative genomics. Greber U, ed., FEMS Microbiol Rev, 39,764–778. https://doi.org/10.1093/femsre/fuv031

90.

Chiara M, Manzari C, Lionetti C et al (2016) Geographic population structure in Epstein-Barr virus revealed by comparative genomics. Genome Biol. Evol 8:3284–3291. https://doi.org/10.1093/gbe/evw226 CrossRefPubMedPubMedCentral

91.

Severson DW, Behura SK (2012) Mosquito genomics: progress and challenges. Annu Rev Entomol 57:143–166. https://doi.org/10.1146/annurev-ento-120710-100651 CrossRefPubMed

92.

Tang Y, Rodpradit P, Chinnawirotpisan P et al (2010) Comparative analysis of full-length genomic sequences of 10 dengue serotype 1 viruses associated with different genotypes, epidemics, and disease severity isolated in Thailand over 22 years. Am J Trop Med Hyg 83:1156–1165. https://doi.org/10.4269/ajtmh.2010.10-0052 CrossRefPubMedPubMedCentral

93.

Osman O, Fong MY, Devi S (2008) Complete genome sequence analysis of dengue virus type 2 isolated in Brunei. Virus Res 135:48–52. https://doi.org/10.1016/j.virusres.2008.02.006 CrossRefPubMed

94.

King C-C, Chao D-Y, Chien L-J et al (2008) Comparative analysis of full genomic sequences among different genotypes of dengue virus type 3. Virol J 5:63. https://doi.org/10.1186/1743-422X-5-63 CrossRefPubMedPubMedCentral

Titel: From dengue to Zika: the wide spread of mosquito-borne arboviruses
verfasst von: Shivani Sukhralia
Mansi Verma
Shruthi Gopirajan
P. S. Dhanaraj
Rup Lal
Neeti Mehla
Chhaya Ravi Kant
Publikationsdatum: 28.09.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 1/2019
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-018-3375-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

From dengue to Zika: the wide spread of mosquito-borne arboviruses

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

The downside of antimicrobial agents for wound healing

Performance of rapid antimicrobial susceptibility testing by disk diffusion on MHR-SIR agar directly on urine specimens

Rifabutin induced multinucleated hepatocytes in rats: an overview with future prospects

Evaluation of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for identifying Burkholderia pseudomallei and Burkholderia thailandensis isolates

Respiratory syncytial virus (RSV) infection in children with medical complexity

STI with Mycoplasma genitalium—more common than Chlamydia trachomatis in patients attending youth clinics in Sweden

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin